Cargando...
Opportunities and challenges for TCR mimic antibodies in cancer therapy
INTRODUCTION: Monoclonal antibodies (mAbs) are potent cancer therapeutic agents, but exclusively recognize cell-surface targets whereas most cancer-associated proteins are found intracellularly. Hence, potential cancer therapy targets such as overexpressed self-proteins, activated oncogenes, mutated...
Guardado en:
| Publicado en: | Expert Opin Biol Ther |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4936943/ https://ncbi.nlm.nih.gov/pubmed/27094818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2016.1176138 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|